<DOC>
	<DOCNO>NCT00258713</DOCNO>
	<brief_summary>The purpose study determine safety efficacy voclosporin patient plaque psoriasis .</brief_summary>
	<brief_title>A 36-Week Extension Protocol ISA04-03</brief_title>
	<detailed_description>Psoriasis chronic skin condition significant impact patient 's physical mental well . The common form psoriasis plaque psoriasis . Targeted treatment psoriasis report recently , yet cyclosporine , calcineurin inhibitor ( CNi ) remain one treatment great efficacy . Voclosporin represent possibility calcineurin inhibitor efficacious cyclosporine A , also improve toxicity profile .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Males female age 1866 year inclusive time visit 1 . Diagnosed plaque psoriasis ≥ 6 month . Currently participate study ISA0403 complete study include Visit 9 study ISA0403 . Not pregnant nursing planning become pregnant course study Sexuallyactive woman childbearing potential ( include &lt; 1 year postmenopausal ) sexuallyactive men practice highly effective method birth control . A highly effective method birth control define one result low failure rate ( i.e. , less 1 % per year ) use consistently correctly include implant , injectables , combine oral contraceptive , doublebarrier method , sexual abstinence , sterile partner . Sexuallyactive men woman childbearing potential continue practice contraception outline treatment ≥ 3 month last dose voclosporin . Written inform consent prior study related procedure . Able keep study appointment cooperate study requirement , opinion investigator . Has generalize erythrodermic , guttate , pustular psoriasis . Have dermatosis would interfere evaluation psoriasis , discretion investigator . A current malignancy history malignancy within 5 year history lymphoma time . Subjects enrol history squamous basal cell carcinoma surgically excise remove curettage electrodesiccation . Has current , uncontrolled bacterial , viral , fungal infection require intravenous antibiotic antifungal . Has current streptococcal infection require oral antibiotic . A known history tuberculosis . Serologic evidence know latent human immunodeficiency virus ( HIV ) , hepatitis B ( HBV ) hepatitis C ( HCV ) virus . Uncontrolled hypertension define 3 reading systolic blood pressure ≥ 150 mm Hg diastolic blood pressure ≥ 90 mm Hg . MDRD GFR ≤ 60 mL/min . Unstable renal function ( variation GFR ≥ 30 % ) . Alanine transaminase , aspartate transaminase , gammaglutamyl transferase ≥ 3x upper limit normal ( ULN ) . White blood cell count ≤ 2.8x10 ninth power/L . Triglycerides ≥ 3x ULN . Is currently take require follow prohibited medication treatment treatment period : drug potentiate nephrotoxicity voclosporin chronic NSAID 's ACE inhibitor , drug interfere 's pharmacokinetics ; drug consider contribute psoriasis flare ; , systemic topical psoriasis medication ( include psoralen/ultraviolet A light treatment ) may interfere assessment study drug efficacy . Has take biological agent ( ) , except flu shot , tetanus shot , booster , within 3 month start treatment . Biological agent include virus , therapeutic serum , toxin , antitoxin , analogous product applicable prevention , treatment , cure disease injuries man . A history clinically define allergy cyclosporine constituent voclosporin formulation ( vitamin E , medium chain triglyceride oil , Tween 40 , ethanol ) . A history alcoholism drug addiction within 1 year prior study entry . Weighs &lt; 45 kg ( 99 lb ) &gt; 140 kg ( 308 lb ) . A history disease , include mental/emotional disorder would interfere subject 's participation study , might cause administration ISA247 pose significant risk subject , opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Randomized Controlled Trials</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Adult</keyword>
	<keyword>Chronic Disease</keyword>
	<keyword>Dermatologic Agents</keyword>
	<keyword>Female</keyword>
	<keyword>Humans</keyword>
	<keyword>Male</keyword>
	<keyword>Middle Aged</keyword>
	<keyword>Severity Illness Index</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Double-Blind Method</keyword>
</DOC>